Changes in BNP, hs-CRP and TIMI risk index with addition of tirofiban during primary percutaneous coronary intervention for acute STEMI: a prospective observational cohort study


Creative Commons License

Kurt I. H. , Demirkol S., ÜNAL İ., Batur M. K.

ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.12, ss.107-114, 2012 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 12 Konu: 2
  • Basım Tarihi: 2012
  • Doi Numarası: 10.5152/akd.2012.035
  • Dergi Adı: ANATOLIAN JOURNAL OF CARDIOLOGY
  • Sayfa Sayısı: ss.107-114

Özet

Objective: This study aimed to investigate the relationship of tirofiban, added to the treatment of acute ST-elevation myocardial infarction (STEMI) patients underwent primary percutaneous coronary intervention (PCI), with changes in the TIMI risk index (TRI) of TIMI flow, B-type natriuretic peptide (BNP) and high-sensitive C-reactive protein (hs-CRP) levels.